Rift Valley Fever

Tropical Infectious Diseases: Principles, Pathogens and Practice

Volumn , Issue , 2011, Pages 462-465

  Peters, C J ^a   Makino, Shinji ^b   Morrill, J C ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85136081556     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-3935-5.00069-0     Document Type: Chapter

References (146)

1. Tesh RB, Peters CJ, Meegan JM Studies on the antigenic relationship among phleboviruses. Am J Trop Med Hyg 1982, 31:149.
2. Xu F, Liu D, Nunes MRT, et al. Antigenic and genetic relationships among Rift Valley fever virus and other selected members of the genus Phlebovirus (Bunyaviridae). Am J Trop Med Hyg 2007, 76:1194.
3. Liu DY, Tesh RB, Travassos da Rosa AP, et al. Phylogenetic relationships among members of the genus Phlebovirus (Bunyaviridae) based on partial M segment sequence analyses. J Gen Virol 2003, 84:465.
4. Schmaljohn CS, Nichol ST Bunyaviridae. Fields Virology 2007, 1741. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia. 5th ed. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
5. Muller R, Poch O, Delarue M, et al. Rift Valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases. J Gen Virol 1994, 75:1345.
6. Zamoto-Niikura A, Terasaki K, Ikegami T, et al. Rift Valley fever virus L protein forms a biologically active oligomer. J Virol 2009, 83:12779.
7. Gerrard SR, Nichol ST Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein. J Virol 2002, 76:12200.
8. Bird BH, Albarino CG, Hartman AL, et al. Rift Valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals. J Virol 2008, 82:2681.
9. Bird BH, Albarino CG, Nichol ST Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. Virology 2007, 362:10.
10. Won S, Ikegami T, Peters CJ, Makino S NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. J Virol 2006, 80:8274.
11. Won S, Ikegami T, Peters CJ, Makino S NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis. J Virol 2007, 81:13335.
12. Spik K, ShurtleffA, McElroy AK, et al. Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus. Vaccine 2006, 24:4657.
13. Caplen H, Peters CJ, Bishop DH Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol 1985, 66:2271.
14. Ikegami T, Won S, Peters CJ, Makino S Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment. J Virol 2005, 79:12106.
15. Higashihara M Heat- and acid-labile virus-inhibiting factor or interferon induced by Rift Valley fever virus in mice. Jpn J Microbiol 1971, 15:482.
16. Morrill JC, Jennings GB, CosgriffTM, et al. Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha. Rev Infect Dis 1989, 11:S815.
17. Anderson GW, Peters CJ Viral determinants of virulence for Rift Valley fever (RVF) in rats. Microb Pathog 1988, 5:241.
18. Le MN, Mansuroglu Z, Leger P, et al. A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog 2008, 4:e13.
19. Billecocq A, Spiegel M, Vialat P, et al. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 2004, 78:9798.
20. Le MN, Dubaele S, Proietti De SL, et al. TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 2004, 116:541.
21. Bouloy M, Janzen C, Vialat P, et al. Genetic evidence for an interferon-antagonistic function of Rift Valley fever virus nonstructural protein NSs. J Virol 2001, 75:1371.
22. Ikegami T, Won S, Peters CJ, Makino S Rescue of infectious Rift Valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol 2006, 80:2933.
23. Ellis DS, Shirodaria PV, Fleming E, Simpson DI Morphology and development of Rift Valley fever virus in Vero cell cultures. J Med Virol 1988, 24:161.
24. Freiberg AN, Sherman MB, Morais MC, et al. Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography. J Virol 2008, 82:10341.
25. Huiskonen JT, Overby AK, Weber F, Grunewald K Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers. J Virol 2009, 83:3762.
26. Sherman MB, Freiberg AN, Holbrook MR, Watowich SJ Single-particle cryo-electron microscopy of Rift Valley fever virus. Virology 2009, 387:11.
27. Peters CJ, Anderson GW Pathogenesis of Rift Valley fever. Rift Valley Fever 1981, 21. Karger, Basel. N. Goldblum, T.A. Swartz, M.A. Klingberg (Eds.).
28. Swanpoel R, Coetzer JAW Rift Valley fever. Infectious Diseases of Livestock 2004, 1037. Oxford University Press, Cape Town. 2nd ed. J.A.W. Coetzer, R.C. Tustin (Eds.).
29. Billecocq A, Vialat P, Bouloy M Persistent infection of mammalian cells by Rift Valley fever virus. J Gen Virol 1996, 77:3053.
30. Daubney R, Hudson JR, Garnham PC Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep, cattle and man from East Africa. J Pathol Bacteriol 1931, 34:545.
31. Gear J, De Meillon B, Le Roux AF, et al. Rift Valley fever in South Africa; a study of the 1953 outbreak in the Orange Free State, with special reference to the vectors and possible reservoir hosts. S Afr Med J 1955, 29:514.
32. Gear J, De Meillon B, Measroch V, et al. Rift Valley fever in South Africa. 2. The occurrence of human cases in the Orange Free State, the North-Western Cape Province, the Western and Southern Transvaal. B. Field and laboratory investigations. S Afr Med J 1951, 25:908.
33. Weiss KE Rift Valley fever - a review. Bull Epizoot Dis Afr 1957, 5:431.
34. Peters C Emergence of Rift Valley fever. Emerging Diseases: Factors in the Emergence of Arbovirus Diseases 1997, 253. Elsevier, Paris. J.F. Saluzzo, B. Dodet (Eds.).
35. Swanepoel R, Coetzer JAW Rift Valley fever. Infectious Diseases of Livestock with Special Reference to Southern Africa 1994, 688. Oxford University Press, Cape Town. J.A.W. Coetzer, G.R. Thomson, R.C. Tustin (Eds.).
36. Davies FG, Linthicum KJ, James AD, Davies FG Rainfall and epizootic Rift Valley fever. Bull WHO 1985, 63:941.
37. Davies FG Observations on the epidemiology of Rift Valley fever in Kenya. J Hyg 1975, 75:219.
38. Swanepoel R Observations on Rift Valley fever in Zimbabwe. Rift Valley fever 1981, Vol. 3:83. Karger, Basel, Proceedings of a Workshop and Rift Valley fever, Herzlia, Israel, March 18-21, 1980.
39. Linthicum KJ, Bailey CL, Davies FG, et al. The horizontal distribution of Aedes pupae and their subsequent adults within a flooded dambo in Kenya: implications for Rift Valley fever virus control. J Am Mosq Control Assoc 1988, 4:551.
40. Linthicum KJ, Davies FG, Kairo A, Bailey CL Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya. J Hyg 1985, 95:197.
41. Linthicum KJ, Davies FG, Bailey CL, Kairo A Mosquito species succession in a dambo in an East African forest. Mosq News 1983, 43:464.
42. Turell MJ, Linthicum KJ, Patrican LA, et al. Vector competence of selected African mosquito (Diptera: Culicidae) species for Rift Valley fever virus. J Med Entomol 2008, 45:102.
43. Monath TP The Arboviruses: Epidemiology and Ecology 1988, CRC Press, Boca Raton, FL.
44. Romoser WS, Faran ME, Bailey CL Newly recognized route of arbovirus dissemination from the mosquito (Diptera: Culicidae) midgut. J Med Entomol 1987, 24:431.
45. Wolhuter J, Bengis RG, Reilly BK, Cross PC Clinical demodicosis in African buffalo (Syncerus caffer) in the Kruger National Park. J Wildl Dis 2009, 45:502.
46. Davies FG, Logan TM, Binepal Y, Jessen P Rift Valley fever virus activity in East Africa in 1989. Vet Rec 1992, 130:247.
47. Swanepoel R Studies on the epidemiology of Rift Valley Fever. J S Afr Vet Assoc 1976, 47:93.
48. Davies FG, Kilelu E, Linthicum KJ, Pegram RG Patterns of Rift Valley fever activity in Zambia. Epidemiol Infect 1992, 108:185.
49. Linthicum KJ, Anyamba A, Tucker CJ, et al. Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science 1999, 285:397.
50. Anyamba A, Chretien JP, Small J, et al. Developing global climate anomalies suggest potential disease risks for 2006-2007. Int J Health Geographics [Electronic Resource] 2006, 5:60.
51. Anyamba A, Linthicum KJ, Tucker CJ, et al. Climate-disease connections: Rift Valley fever in Kenya. Cadernos Saude Publica 2001, 17:133.
52. Linthicum KJ, Bailey CL, Davies FG, Tucker CJ Detection of Rift Valley fever viral activity in Kenya by satellite remote sensing imagery. Science 1987, 235:1656.
53. Linthicum KJ, Bailey CL, Tucker CJ, et al. Application of polar-orbiting, meteorological satellite data to detect flooding of Rift Valley fever virus vector mosquito habitats in Kenya. Med Vet Entomol 1990, 4:433.
54. Ksiazek TG, Jouan A, Meegan JM, et al. Rift Valley fever among domestic animals in the recent West African outbreak. Res Virol 1989, 140:67.
55. Jouan A, Coulibaly I, Adam F, et al. Analytical study of a Rift Valley fever epidemic. Res Virol 1989, 140:175.
56. Jouan A, Le GB, Digoutte JP, et al. An RVF epidemic in southern Mauritania. Ann Inst Pasteur Virol 1988, 139:307.
57. Digoutte JP, Peters CJ General aspects of the 1987 Rift Valley fever epidemic in Mauritania. Res Virol 1989, 140:27.
58. Saluzzo JF, Chartier C, Bada R, et al. La fièvre de la vallée du Rift en Afrique de l'Ouest. [Rift Valley fever in Western Africa]. Rev Elev Med Vet Pays Trop 1987, 40:215.
59. Saluzzo JF, Digoutte JP, Chartier C, et al. Focus of Rift Valley fever virus transmission in southern Mauritania. Lancet 1987, 1:504.
60. Vignolles C, Lacaux JP, Tourre YM, et al. Rift Valley fever in a zone potentially occupied by Aedes vexans in Senegal: dynamics and risk mapping. Geospatial Health 2009, 3:211.
61. Tourre YM, Lacaux JP, Vignolles C, et al. Mapping of zones potentially occupied by Aedes vexans and Culex poicilipes mosquitoes, the main vectors of Rift Valley fever in Senegal. Geospatial Health 2008, 3:69.
62. Thonnon J, Picquet M, Thiongane Y, et al. Rift valley fever surveillance in the lower Senegal River basin: update 10 years after the epidemic. Trop Med Int Health 1999, 4:580.
63. Zeller HG, Fontenille D, Traore-Lamizana M, et al. Enzootic activity of Rift Valley fever virus in Senegal. Am J Trop Med Hyg 1997, 56:265.
64. Gad AM, Feinsod FM, Allam IH, et al. A possible route for the introduction of Rift Valley fever virus into Egypt during 1977. J Trop Med Hyg 1986, 89:233.
65. Hoogstraal H, Meegan JM, Khalil GM, Adham FK The Rift Valley fever epizootic in Egypt 1977-78. 2. Ecological and entomological studies. Trans R Soc Trop Med Hyg 1979, 73:624.
66. Laughlin LW, Girgis NI, Meegan JM, et al. Clinical studies on Rift Valley fever. Part 2: Ophthalmologic and central nervous system complications. J Egypt Public Health Assoc 1978, 53:183.
67. Meegan JM The Rift Valley fever epizootic in Egypt 1977-78. 1. Description of the epizootic and virological studies. Trans R Soc Trop Med Hyg 1979, 73:618.
68. Meegan JM, Shope RE Emerging concepts on Rift Valley fever. Perspect Virol 1981, 11:267.
69. Abd el-Rahim IH, Abd el-Hakim U, Hussein M An epizootic of Rift Valley fever in Egypt in 1997. Rev Sci Tech 1999, 18:741.
70. Abu-Elyazeed R, el-Sharkawy S, Olson J, et al. Prevalence of anti-Rift-Valley-fever IgM antibody in abattoir workers in the Nile delta during the 1993 outbreak in Egypt. Bull WHO 1996, 74:155.
71. Arthur RR, el-Sharkawy MS, Cope SE, et al. Recurrence of Rift Valley fever in Egypt. Lancet 1993, 342:1149.
72. Anyamba A, Chretien JP, Formenty PB, et al. Rift Valley Fever potential, Arabian Peninsula. Emerg Infect Dis 2006, 12:518.
73. Centers for Disease Control and Prevention (CDC) Update: outbreak of Rift Valley fever - Saudi Arabia, August-November 2000. MMWR Morb Mortal Wkly Rep 2000, 49:982.
74. Davies FG Risk of a Rift Valley fever epidemic at the haj in Mecca, Saudi Arabia. Rev Sci Tech 2006, 25:137.
75. Miller BR, Godsey MS, Crabtree MB, et al. Isolation and genetic characterization of Rift Valley fever virus from Aedes vexans arabiensis, Kingdom of Saudi Arabia. Emerg Infect Dis 2002, 8:1492.
76. Shoemaker T, Boulianne C, Vincent MJ, et al. Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000-01. Emerg Infect Dis 2002, 8:1415.
77. Rift Valley fever, Yemen (update). Weekly Epidemiol Rec 2000 13, 75:329.
78. Abdo-Salem S, Gerbier G, Bonnet P, et al. Descriptive and spatial epidemiology of Rift Valley fever outbreak in Yemen 2000-2001. Ann NY Acad Sci 2006, 1081:240.
79. Sissoko D, Giry C, Gabrie P, et al. Rift Valley fever, Mayotte, 2007-2008. Emerg Infect Dis 2009, 15:568.
80. Turell MJ, Kay BH Susceptibility of selected strains of Australian mosquitoes (Diptera: Culicidae) to Rift Valley fever virus. J Med Entomol 1998, 35:132.
81. Gargan TP, Clark GG, Dohm DJ, Turell MJ, Bailey CL Vector potential of selected North American mosquito species for Rift Valley fever virus. Am J Trop Med Hyg 1988, 38:440.
82. Turell MJ, Bailey CL, Beaman JR Vector competence of a Houston, Texas strain of Aedes albopictus for Rift Valley fever virus. J Am Mosq Control Assoc 1988, 4:94.
83. Turell MJ, Rossi CA, Bailey CL Effect of extrinsic incubation temperature on the ability of Aedes taeniorhynchus and Culex pipiens to transmit Rift Valley fever virus. Am J Trop Med Hyg 1985, 34:1211.
84. Keefer GV, Zebarth GL, Allen WP Susceptibility of dogs and cats to Rift Valley fever by inhalation or ingestion of virus. J Infect Dis 1972, 125:307.
85. Anderson GW, Lee JO, Anderson AO, et al. Efficacy of a Rift Valley fever virus vaccine against an aerosol infection in rats. Vaccine 1991, 9:710.
86. Brown JL, Dominik JW, Morrissey RL Respiratory infectivity of a recently isolated Egyptian strain of Rift Valley fever virus. Infect Immun 1981, 33:848.
87. Miller WS, Demchak P, Rosenberger CR, et al. Stability and infectivity of airborne yellow fever and Rift Valley fever viruses. Am J Epidemiol 1963, 77:114.
88. Kruse RH, Wedum AG Cross infection with eighteen pathogens among caged laboratory animals. Lab Anim Care 1970, 20:541.
89. Boiro I, Konstaninov OK, Numerov AD [Isolation of Rift Valley fever virus from bats in the Republic of Guinea] [in French]. Bull Soc Pathol Exot Filiales 1987, 80:62.
90. Francis T, Magill TP Rift Valley fever: a report of three cases of laboratory infection and the experimental transmission of the disease to ferrets. J Exp Med 1935, 62:433.
91. Smithburn KC, Mahaffy AF Rift Valley fever: accidental infections among laboratory workers. J Immunol 1949, 62:213.
92. Tomori O, Monath TP, O'Connor EH, et al. Arbovirus infections among laboratory personnel in Ibadan, Nigeria. Am J Trop Med Hyg 1981, 30:855.
93. Hoch AL, Gargan TP, Bailey CL Mechanical transmission of Rift Valley fever virus by hematophagous Diptera. Am J Trop Med Hyg 1985, 34:188.
94. Smithburn KC, Mahaffy AF Rift Valley fever; accidental infections among laboratory workers. J Immunol 1949, 62:213.
95. Matumoto M, Nishi I, Saburi Y [Multiplication of the neurotropic strain of Rift Valley fever virus in the spleen and liver of mice] [in French]. C R Seances Soc Biol Filiales 1958, 152:1623.
96. Kahlon SS, Peters CJ, Leduc J, et al. Severe Rift Valley fever may present with a characteristic clinical syndrome. Am J Trop Med Hyg 2010, 82:371.
97. Gear JH Clinical aspects of African viral hemorrhagic fevers. Rev Infect Dis 1989, 11(suppl 4):S777.
98. van Velden DJ, Meyer JD, Olivier J, et al. Rift Valley fever affecting humans in South Africa: a clinicopathological study. S Afr Med J 1977, 51:867.
99. Swanepoel R Observations on Rift Valley fever in Zimbabwe. Rift Valley fever: Proceedings of a Workshop and Rift Valley Fever Herzlia, Israel, March 18-21, 1980 1981, Vol. 3:83. Karger, Basel.
100. Laughlin LW, Meegan JM, Strausbaugh LJ, et al. Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness. Trans R Soc Trop Med Hyg 1979, 73:630.
101. Alrajhi AA, Al-Semari A, Al-Watban J Rift Valley fever encephalitis. Emerg Infect Dis 2004, 10:554.
102. Maar SA, Swanepoel R, Gelfand M Rift Valley fever encephalitis. A description of a case. Cent Afr J Med 1979, 25:8.
103. Riou O, Philippe B, Jouan A, et al. [Neurologic and neurosensory forms of Rift Valley fever in Mauritania] [in French]. Bull Soc Pathol Exot Filiales 1989, 82:605.
104. LaBeaud AD, Muchiri EM, Ndzovu M, et al. Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya. Emerg Infect Dis 2008, 14:1240.
105. Al-Hazmi A, Al-Rajhi AA, Abboud EB, et al. Ocular complications of Rift Valley fever outbreak in Saudi Arabia. Ophthalmology 2005, 112:313.
106. Siam AL, Meegan JM, Gharbawi KF Rift Valley fever ocular manifestations: observations during the 1977 epidemic in Egypt. Br J Ophthalmol 1980, 64:366.
107. Ayoub M, Barhoma G, Zaghlol I Ocular manifestations of Rift Valley fever. Bull Ophthalmol Soc Egypt 1978, 71:125.
108. Madani TA, Al-Mazrou YY, Al-Jeffri MH, et al. Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin Infect Dis 2003 15, 37:1084.
109. Al-Hazmi M, Ayoola EA, Abdurahman M, et al. Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans. Clin Infect Dis 2003, 36:245.
110. El Imam M, El Sabiq M, Omran M, et al. Acute renal failure associated with the Rift Valley fever: a single center study. Saudi J Kidney Dis Transpl 2009, 20:1047.
111. Morrill JC, Peters CJ Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys. Vaccine 2003, 20(21):2994.
112. Peters CJ Pathogenesis of viral hemorrhagic fevers. Viral Pathogenesis 1997, 779. Lippincott-Raven, Philadelphia. N. Nathanson, R. Ahmed, F. Gonzalez-Scarano (Eds.).
113. Morrill JC, Czarniecki CW, Peters CJ Recombinant human interferon-gamma modulates Rift Valley fever virus infection in the rhesus monkey. J Interferon Res 1991, 11:297.
114. Morrill JC, Knauert FK, Ksiazek TG, et al. Rift Valley fever infection of rhesus monkeys: implications for rapid diagnosis of human disease. Res Virol 1989, 140:139.
115. CosgriffTM, Morrill JC, Jennings GB, et al. Hemostatic derangement produced by Rift Valley fever virus in rhesus monkeys. Rev Infect Dis 1989, 11(suppl 4):S807.
116. Peters CJ, Liu CT, Anderson GW, et al. Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted. Rev Infect Dis 1989, 11(suppl 4):S743.
117. Peters CJ, Jones D, Trotter R, et al. Experimental Rift Valley fever in rhesus macaques. Arch Virol 1988, 99:31.
118. Findlay G The infectivity of Rift Valley fever for monkeys. Trans R Soc Trop Med Hyg 1932, 26:161.
119. Anderson GWJ, Slone TWJ, Peters CJ The gerbil, Meriones unguiculatus, a model for Rift Valley fever viral encephalitis. Arch Virol 1988, 102:187.
120. Anderson GWJ, Slone TWJ, Peters CJ Pathogenesis of Rift Valley fever virus (RVFV) in inbred rats. Microb Pathog 1987, 2:283.
121. Findlay GM, Howard EM Notes on Rift Valley fever. Arch Gesamte Virusforsch 1951, 4:411.
122. Morrill JC, Jennings GB, Johnson AJ, et al. Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response. Arch Virol 1990, 110:195.
123. Rippy MK, Topper MJ, Mebus CA, Morrill JC Rift Valley fever virus-induced encephalomyelitis and hepatitis in calves. Vet Pathol 1992, 29:495.
124. Yoser SL, Forster DJ, Rao NA Systemic viral infections and their retinal and choroidal manifestations. Surv Ophthalmol 1993, 37:313.
125. Peters CJ, Meegan J Rift Valley fever. Viral Zoonoses 1981, 403. CRC Press, Boca Raton, FL. G.W. Beran, J.H. Steele (Eds.).
126. Bird BH, Bawiec DA, Ksiazek TG, et al. Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus. J Clin Microbiol 2007, 45:3506.
127. Peters CJ, Reynolds JA, Slone TW, et al. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator. Antiviral Res 1986, 6:285.
128. Peters CJ The role of antivirals in responding to biological threats. Biological Threats and Terrorism, Assessing the Science and Response Capabilities. Workshop Summary of the Forum on Emerging Infections, Board on Global Health, Institute of Medicine 2002, 119. National Academy Press, Washington, DC. S.L. Knobler, A.A.F. Mahmoud, L.A. Pray (Eds.).
129. Niklasson BS, Meadors GF, Peters CJ Active and passive immunization against Rift Valley fever virus infection in Syrian hamsters. Acta Pathol Microbiol Immunol Scand C 1984, 92:197.
130. Kende M, Lupton HW, Rill WL, Levy HB, Canonico PG Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against Rift Valley fever virus infection in mice. Antimicrob Agents Chemother 1987, 31:986.
131. Kende M, Lupton HW, Rill WL, Gibbs P, Levy HB, Canonico PG Ranking of prophylactic efficacy of poly(ICLC) against Rift Valley fever virus infection in mice by incremental relative risk of death. Antimicrob Agents Chemother 1987, 31:1194.
132. Kende M Prophylactic and therapeutic efficacy of poly(I, C)-LC against Rift Valley fever virus infection in mice. J Biol Response Mod 1985, 4:503.
133. Kende M, Alving CR, Rill WL, et al. Enhanced efficacy of liposome-encapsulated ribavirin against Rift Valley fever virus infection in mice. Antimicrob Agents Chemother 1985, 27:903.
134. Logan TM, Linthicum KJ, Wagateh JN, et al. Pretreatment of floodwater Aedes habitats (dambos) in Kenya with a sustained-release formulation of methoprene. J Am Mosq Control Assoc 1990, 6:736.
135. Linthicum KJ, Logan TM, Thande PC, et al. Efficacy of a sustained-release methoprene formulation on potential vectors of Rift Valley fever virus in field studies in Kenya. J Am Mosq Control Assoc 1989, 5:603.
136. Barnard BJ Rift Valley fever vaccine - antibody and immune response in cattle to a live and an inactivated vaccine. J South African Vet Assoc 1979, 50:155.
137. Smithburn KC Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine. Br J Exp Pathol 1949, 30:1.
138. Botros B, Omar A, Elian K, et al. Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine. J Med Virol 2006, 78:787.
139. Coetzer JA, Barnard BJ Hydrops amnii in sheep associated with hydranencephaly and arthrogryposis with wesselsbron disease and Rift Valley fever viruses as aetiological agents. Onderstepoort J Vet Res 1977, 44:119.
140. Morrill JC, Jennings GB, Caplen H, et al. Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes. Am J Vet Res 1987, 48:1042.
141. Morrill JC, Mebus CA, Peters CJ Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids. Am J Vet Res 1997, 58:1110.
142. Morrill JC, Mebus CA, Peters CJ Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle. Am J Vet Res 1997, 58:1104.
143. Randall R, Binn LN, Harrison VR Immunization against Rift Valley fever. Studies on the immunogenicity of lyophilized formalin-inactivated vaccine. J Immunol 1964, 93:293.
144. Eddy GA, Peters CJ The extended horizons of Rift Valley fever: current and projected immunogens. Prog Clin Biol Res 1980, 47:179.
145. Pittman PR, Liu CT, Cannon TL, et al. Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience. Vaccine 1999, 20(18):181.
146. Ikegami T, Makino S Rift Valley fever vaccines. Vaccine 2009 5, 27(suppl 4):D69.